Viví Ann Flørenes

6.5k citations

108 papers · 5.4k indexed · h-index 42

Molecular Biology top 2%
Oncology top 1%
Cancer Research top 2%
Pulmonary and Respiratory Medicine top 5%
Immunology top 5%

Co-authors: Gunhild M. Mælandsmo Øystein Fodstad Ben Davidson Ruth Holm Robert S. Kerbel Joyce M. Slingerland Ola Myklebost Janusz Rak
Topics: Melanoma and MAPK Pathways (19 papers)Cancer-related Molecular Pathways (19 papers)Ovarian cancer diagnosis and treatment (14 papers)
Cited by: Oncology Cancer Research Immunology and Allergy
Journals: Nature Medicine The Journal of Cell Biology PLoS ONE
Partner nations: Norway United States Canada

In The Last Decade

Viví Ann Flørenes

106 papers receiving 5.3k citations

Peers

Countries citing papers authored by Viví Ann Flørenes

Since Specialization

Citations

This map shows the geographic impact of Viví Ann Flørenes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viví Ann Flørenes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viví Ann Flørenes more than expected).

Fields of papers citing papers by Viví Ann Flørenes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Viví Ann Flørenes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viví Ann Flørenes. The network helps show where Viví Ann Flørenes may publish in the future.

Co-authorship network of co-authors of Viví Ann Flørenes

This figure shows the co-authorship network connecting the top 25 collaborators of Viví Ann Flørenes. A scholar is included among the top collaborators of Viví Ann Flørenes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Viví Ann Flørenes. Viví Ann Flørenes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeting AXL and the DNA Damage Response Pathway as a Novel Therapeutic Strategy in Melanoma 2019 ·Molecular Cancer Therapeutics ·Karine Flem‐Karlsen,(unknown),(unknown),Mads H. Haugen,(unknown),(unknown),Hans Petter Gullestad,Robert Michael Hermann,Gunhild M. Mælandsmo,Viví Ann Flørenes	19
2	hvTRA, a novel TRAIL receptor agonist, induces apoptosis and sustained growth retardation in melanoma 2016 ·Cell Death Discovery ·Karianne G. Fleten,Viví Ann Flørenes,Lina Prasmickaite,Oliver Hill,Jaromir Sykora,Gunhild M. Mælandsmo,Birgit Engesæter	10
3	Flow cytometric measurement of cellular FLICE‐inhibitory protein (c‐FLIP) in ovarian carcinoma effusions 2011 ·Cytopathology ·Hiep Phuc Dong,Anne Katrine Ree Rosnes,(unknown),(unknown),Viví Ann Flørenes,Claes G. Tropé,Bjørn Risberg,Ben Davidson	2
4	Overexpression of CDC25B, CDC25C and phospho-CDC25C (Ser216) in vulvar squamous cell carcinomas are associated with malignant features and aggressive cancer phenotypes 2010 ·BMC Cancer ·Zhihui Wang,Claes G. Tropé,Viví Ann Flørenes,Zhenhe Suo,Jahn M. Nesland,Ruth Holm	40
5	Biological effects induced by insulin‐like growth factor binding protein 3 (IGFBP‐3) in malignant melanoma 2009 ·International Journal of Cancer ·(unknown),Ana Slipicevic,Ben Davidson,Ragnar S. Faye,Gunhild M. Mælandsmo,Viví Ann Flørenes	19
6	FAP-α and uPA Show Different Expression Patterns in Premalignant and Malignant Esophageal Lesions 2008 ·Ultrastructural Pathology ·Mariusz Adam Goscinski,Zhenhe Suo,Viví Ann Flørenes,Ljiljana Vlatkovic,Jahn M. Nesland,Karl-Erik Giercksky	35
7	Dipeptidyl peptidase IV expression in cancer and stromal cells of human esophageal squamous cell carcinomas, adenocarcinomas and squamous cell carcinoma cell lines 2008 ·Apmis ·Mariusz Adam Goscinski,(unknown),Jahn M. Nesland,Viví Ann Flørenes,Karl‐Erik Giercksky	21
8	Proteomic Analysis of Malignant Ovarian Cancer Effusions as a Tool for Biologic and Prognostic Profiling 2006 ·Clinical Cancer Research ·Ben Davidson,Virginia Espina,Seth M. Steinberg,Viví Ann Flørenes,Lance A. Liotta,Gunnar B. Kristensen,Claes G. Tropé,Aasmund Berner,Elise C. Kohn	62
9	Gene Expression Signatures Differentiate Ovarian/Peritoneal Serous Carcinoma from Diffuse Malignant Peritoneal Mesothelioma 2006 ·Clinical Cancer Research ·Ben Davidson,Zhen Zhang,Lilach Kleinberg,Mei Li,Viví Ann Flørenes,Tian‐Li Wang,Ie‐Ming Shih	88
10	Variation in gene expression patterns in effusions and primary tumors from serous ovarian cancer patients 2005 ·Molecular Cancer ·Marci E. Schaner,Ben Davidson,Martina L. Skrede,Reuven Reich,Viví Ann Flørenes,Bjørn Risberg,Aasmund Berner,Iris Goldberg,Vered Givant-Horwitz,Claes G. Tropé,Gunnar B. Kristensen,Jahn M. Nesland,Anne‐Lise Børresen‐Dale	22
11	Phorbol ester phorbol-12-myristate-13-acetate promotes anchorage-independent growth and survival of melanomas through MEK-independent activation of ERK1/2 2005 ·Biochemical and Biophysical Research Communications ·Kjersti Jørgensen,Martina L. Skrede,Véronique Cruciani,Svein‐Ole Mikalsen,Ana Slipicevic,Viví Ann Flørenes	27
12	Expression of the nerve growth factor receptors TrkA and p75 in malignant mesothelioma 2004 ·Lung Cancer ·Ben Davidson,Reuven Reich,Philip Lazarovici,Viví Ann Flørenes,Bjørn Risberg,Søren Nielsen,(unknown),Carlos Bedrossian	35
13	Granulin‐epithelin precursor is a novel prognostic marker in epithelial ovarian carcinoma 2004 ·Cancer ·Ben Davidson,Emilyn U. Alejandro,Viví Ann Flørenes,(unknown),Bjørn Risberg,Gunnar B. Kristensen,Claes G. Tropé,Elise C. Kohn	90
14	Expression of Activated TrkA Protein in Melanocytic Tumors: Relationship to Cell Proliferation and Clinical Outcome 2004 ·American Journal of Clinical Pathology ·Viví Ann Flørenes,Gunhild M. Mælandsmo,Ruth Holm,Reuven Reich,Philip Lazarovici,Ben Davidson	30
15	Deacetylase inhibition in malignant melanomas: impact on cell cycle regulation and survival 2004 ·Melanoma Research ·Viví Ann Flørenes,Martina L. Skrede,Kjersti Jørgensen,Jahn M. Nesland	46
16	Clinical and cell line specific expression profiles of a human gene identified in experimental central nervous system metastases. 2002 ·Anticancer Research ·Anne Hansen Ree,Åse Bratland,Roger A. Kroes,(unknown),Viví Ann Flørenes,Joseph R. Moskal,Øystein Fodstad,Øyvind S. Bruland,Gunhild M. Mælandsmo	17
17	Differential expression patterns ofS100a2, S100a4 andS100a6 during progression of human malignant melanoma 1997 ·International Journal of Cancer ·Gunhild M. Mælandsmo,Viví Ann Flørenes,(unknown),Eivind Hovig,Robert S. Kerbel,Øystein Fodstad	154
18	Loss of expression of receptor tyrosine kinase family genesPTK7 andSEK in metastatic melanoma 1997 ·International Journal of Cancer ·David J. Easty,Philip J. Mitchell,Ketan Patel,Viví Ann Flørenes,Richard A. Spritz,Dorothy C. Bennett	114
19	散在性悪性黒色腫の発癌におけるpRb/p16/cdk4/サイクリンD1経路の関与 1996 ·British Journal of Cancer ·Gunhild M. Mælandsmo,Viví Ann Flørenes,Eivind Hovig,Tove Øyjord,Olav Engebraaten,Ruth Holm,(unknown),Øystein Fodstad	4
20	MDM2 Gene Amplification and Transcript Levels in Human Sarcomas: Relationship to TP53 Gene Status 1994 ·JNCI Journal of the National Cancer Institute ·Viví Ann Flørenes,Gunhild M. Mælandsmo,Anne Forus,Åshild Andreassen,Ola Myklebost,Øystein Fodstad	166

About Viví Ann Flørenes

Viví Ann Flørenes is a scholar working on Oncology, Reproductive Medicine and Immunology and Allergy, having authored 108 papers that have together received 5.4k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (19 papers), Cancer-related Molecular Pathways (19 papers) and Ovarian cancer diagnosis and treatment (14 papers). The work is most often cited by research in Oncology (2.2k citations), Cancer Research (1.0k citations) and Immunology and Allergy (343 citations). Viví Ann Flørenes has collaborated with scholars based in Norway, United States and Canada. Frequent co-authors include Gunhild M. Mælandsmo, Øystein Fodstad, Ben Davidson, Ruth Holm, Robert S. Kerbel, Joyce M. Slingerland, Ola Myklebost, Janusz Rak, Jahn M. Nesland and Brad St. Croix. Their work appears in journals such as Nature Medicine, The Journal of Cell Biology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact